| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.32B | 20.35B | 20.14B | 20.00B | 18.29B | 16.84B |
| Gross Profit | 8.88B | 12.64B | 7.08B | 7.03B | 6.52B | 6.03B |
| EBITDA | 7.49B | 6.78B | 5.67B | 5.62B | 5.41B | 4.99B |
| Net Income | 928.00M | 1.11B | 993.00M | 841.00M | 1.61B | 1.66B |
Balance Sheet | ||||||
| Total Assets | 58.85B | 59.61B | 58.02B | 56.14B | 54.05B | 47.99B |
| Cash, Cash Equivalents and Short-Term Investments | 1.30B | 2.62B | 869.00M | 864.00M | 974.00M | 723.00M |
| Total Debt | 31.05B | 31.46B | 29.78B | 27.45B | 25.14B | 20.97B |
| Total Liabilities | 42.49B | 43.03B | 41.23B | 38.83B | 36.41B | 31.92B |
| Stockholders Equity | 15.56B | 15.78B | 15.62B | 16.11B | 16.57B | 15.12B |
Cash Flow | ||||||
| Free Cash Flow | 1.76B | 2.35B | 1.46B | 1.29B | 1.16B | -928.00M |
| Operating Cash Flow | 4.42B | 4.87B | 4.85B | 4.50B | 4.81B | 4.39B |
| Investing Cash Flow | -2.50B | -3.04B | -3.70B | -4.75B | -5.41B | -5.47B |
| Financing Cash Flow | -1.11B | -74.00M | -1.14B | 139.00M | 848.00M | 953.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | C$15.21B | 17.00 | 35.07% | 2.69% | 1.93% | 18.42% | |
71 Outperform | C$15.21B | 17.00 | 35.07% | 2.70% | 1.93% | 18.42% | |
69 Neutral | C$28.52B | 4.05 | 40.28% | 3.94% | 7.44% | 297.46% | |
67 Neutral | C$32.03B | 5.03 | 29.69% | 7.42% | 1.55% | 1496.64% | |
65 Neutral | C$28.52B | 4.05 | 40.28% | 3.89% | 7.44% | 297.46% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | C$26.97B | 29.12 | 6.41% | 9.49% | 0.13% | -23.84% |